Cannabis Use Disorder and Mental Health: What You Need to Know Cannabis is one of the most widely used drugs in the world, and its use as a recreational drug has been enhanced by widespread legalization for personal use. However, cannabis use is not without risks, and the risk [...]
About carmahealthThis author has not yet filled in any details.
So far carmahealth has created 35 blog entries.
Ozempic: A Potential Anti-Addiction Drug? Ozempic is a semaglutide medication originally developed to treat type 2 diabetes and obesity by mimicking the effects of a natural hormone called GLP-1 (glucagon-like peptide 1). GLP-1 is secreted by the gut after eating and helps regulate blood sugar levels and insulin production. [...]
Brixadi vs. Other OUD Medications Brixadi is a new treatment option for people with opioid use disorder (OUD). It is an injectable form of buprenorphine, a medication that helps reduce cravings and withdrawal symptoms from opioids. Brixadi was approved by the FDA in May 2023 and is available in [...]
Brixadi: A New Treatment Option for Opioid Use Disorder Opioid use disorder (OUD) is a chronic and potentially fatal condition that affects millions of people in the US. OUD is characterized by the compulsive use of opioids, such as heroin, fentanyl, or prescription painkillers, despite harmful consequences, an inability [...]
The Wellness-Washing of Ketamine-Assisted Therapy Ketamine has had a “party drug” reputation for decades, but this 1970s, FDA-approved anesthetic is garnering new attention today as a psychedelic treatment for people struggling with depression, trauma and substance misuse. A recent Harper's Bazaar article, "Ketamine's Woo-Woo Rebrand" by Shayla Love, highlights [...]
CARMAhealth applauds the passage of the bipartisan Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R.7666).carmahealth2023-08-27T19:53:04-05:00
Mental Health and Well-Being Act Statement of Carlos F. Tirado, MD,MPH, Chief Medical Officer, MAP Health Management and CARMAhealth On Wednesday, June 22, the U.S. House of Representatives passed the Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R.7666) with a strong bipartisan majority. CARMAHealth applauds the [...]
Texas Good Samaritan Law Op-Ed CARMAhealth’s Founder and Chief Medical Officer Dr. Carlos Tirado recently penned an insightful and relevant op-ed regarding the Texas Legislature’s failure to pass a “Good Samaritan Law”. These laws protect drug users from legal penalty in the event that they have to call and [...]
Meth Addiction: The Lesser-Discussed American Substance Use Epidemic Rampant and escalating fatality has steered the American addiction conversation toward opioids and kept it there; a completely understandable inclination given the universal and indiscriminate nature of opioid use disorder. Prescription drugs, heroin and fentanyl threaten every age group, class and [...]
President Trump Vows to Combat Opioid Addiction in Atlanta Summit Address In August of 2017, President Trump declared the United States opioid epidemic a national emergency, signaling that he would put considerable weight behind finding avenues to combat prescription painkiller addiction and subsequent fatality. That same year, over 70,000 [...]
Vivitrol for Alcohol Use Disorder As CARMAhealth continues to observe Alcohol Awareness Month, we wanted to take the opportunity to touch not only on the causes, sustaining factors and impact of alcohol addiction, but also the pathways to treatment of which sufferers can avail themselves to get help and [...]